In a letter, 23andMe asks Francis Collins, director of the National Institutes of Health, and Margaret Hamburg, commissioner of the Food and Drug Administration, to help develop consistency among genetic testing companies. 23andMe says uniformity is particularly needed in validating and reporting customer data and that will then reduce consumer and physician confusion.